Exchange: NASDAQ·Updated 07:04 PM EDT
BIVI logo

BIVI BioVie Inc

$1.35
$0.11
(8.59%)
Today
Closed $1.39
$0.04
(2.88%)
After Hours
EarningsNov 9
Mkt Cap$10.92M
Vol204,864.00

About BIVI

BioVie, Inc. is a biopharmaceutical company, which engages in discovery, development, and marketing drug therapies for neurological and neurodegenerative disorders, and liver disease. The company was founded on April 10, 2013 and is headquartered in Carson City, NV.
40

Bearish Sentiment

How do you feel about BIVI?

Itinerant
$BIVI I think that Do is a very straightforward guy, and I like that a lot. This is a core holding for me, and I expect it to succeed greatly. JMO
4
Itinerant
$BIVI This market reaction is silly, and perhaps driven by manipulative traders looking to steal cheap shares from retail investors. Institutional ownership is still only about 26%. The data is excellent and provides the intended reliable biomarkers that will drive the P3. Now, the company needs to get on that Fast Track. I bought more.
4
AlertsAndNews
$BIVI dropping phase 2 data tomorrow. BioVie to Host Conference Call to Discuss Topline Data from Phase 2 ADDRESS-LC Trial and the Potential of Bezisterim in Long Covid "today announced that the Company will host a conference call and webcast on Tuesday, September 15, 2026 at 8:30am ET to discuss topline results from its Phase 2 ADDRESS-LC trial"
4
Itinerant
$BIVI The data is excellent. Wall Street is taking the opportunity of the confusion about results in order to exploit stock loss orders. JMO
3
singa_stock
$BIVI $BIVI I appreciate company’s initiative to talk about data even if it is disappointing. Atleast they are not trying to shove it under a rug like many others.
2
mshah1615
$BIVI RedChip Investor Webinar with BioVie (NASDAQ: BIVI) Date & Time Sep 23, 2026 11:00 AM Eastern Time (US and Canada)
2
drivinglate
$BIVI This stands out to me: “I am super excited for the Long COVID community because of this data,” stated Grace McComsey, Professor of Medicine and infectious diseases researcher. “At Case Western Reserve University, we have been a part of almost every negative study so far. It’s great to see a trial showing such potential effectiveness while using a well-tolerated oral drug.”
1
eigthman1
$BIVI I'm reading that to fail that all the points. Not sure what everybody else sees and why this would go up today.
1
Stock_Catcher
$BIVI BioVie Announces Topline Results from Phase 2 ADDRESS‑LC Trial Evaluating Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID
1
TJ12000
$BIVI people are finally starting to understand not to trust gypsy companies. Took some convincing
mshah1615
$BIVI i noticed that short borrowing rate is dropping like Rock i used to get 150 % Today only 38% I think there Shorts Covering Still i think BIVIW is BEST BUY

Advertisement|Remove ads.